BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29656766)

  • 1. Hereditary paraganglioma-pheochromocytoma syndrome.
    Sanchez Cifuentes A; Candel Arenas MF; Albarracín Marín-Blazquez A
    Med Clin (Barc); 2018 Nov; 151(10):e57-e58. PubMed ID: 29656766
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosing patients with hereditary paraganglial tumours.
    Erlic Z; Neumann HP
    Lancet Oncol; 2009 Aug; 10(8):741. PubMed ID: 19647193
    [No Abstract]   [Full Text] [Related]  

  • 3. Late diagnosis of an index case of SDH-related paraganglioma/pheochromocytoma syndrome.
    Sánchez-Pacheco Tardón M; Serrano Corredor S; Carrión A; Mauri M; Yuste A
    Endocrinol Nutr; 2012 Feb; 59(2):148-50. PubMed ID: 22138625
    [No Abstract]   [Full Text] [Related]  

  • 4. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 5. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
    Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
    Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma and paraganglioma: imaging characteristics.
    Baez JC; Jagannathan JP; Krajewski K; O'Regan K; Zukotynski K; Kulke M; Ramaiya NH
    Cancer Imaging; 2012 May; 12(1):153-62. PubMed ID: 22571874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
    Barletta JA; Hornick JL
    Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
    Lalloo F
    Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports.
    Hirose R; Tsurutani Y; Sugisawa C; Inoue K; Suematsu S; Nagata M; Hasegawa N; Kakuta Y; Yonamine M; Takekoshi K; Kimura N; Saito J; Nishikawa T
    J Med Case Rep; 2021 May; 15(1):282. PubMed ID: 34020699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.
    Taïeb D; Timmers H; Pacak K
    Horm Metab Res; 2019 Jul; 51(7):414-418. PubMed ID: 29618137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal Paraganglioma and Pheochromocytoma Due to Truncated SDHD Mutation.
    Zuo Y; Li X; Wu X; Zhou J; Wang J; Wang J; Wu Z; Li H; Zhang X
    Urology; 2018 Jun; 116():63-67. PubMed ID: 29545045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4.
    Gill AJ; Pachter NS; Clarkson A; Tucker KM; Winship IM; Benn DE; Robinson BG; Clifton-Bligh RJ
    N Engl J Med; 2011 Mar; 364(9):885-6. PubMed ID: 21366490
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
    Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Solórzano CC; Kim LT
    Ann Surg Oncol; 2020 May; 27(5):1329-1337. PubMed ID: 32112212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Succinate Dehydrogenase Mutations as Familial Pheochromocytoma Syndromes.
    Lui MS; Clemente-Gutierrez U; Skefos CM; Perrier ND
    Surg Oncol Clin N Am; 2023 Apr; 32(2):289-301. PubMed ID: 36925186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma].
    Broudin C; Favier J; Verkarre V; Méatchi T
    Ann Pathol; 2020 Apr; 40(2):134-141. PubMed ID: 32146049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrapericardical paraganglioma associated with mutation in succinate dehydrogenase enzyme gene].
    Diéguez Felechosa M; Pun Y; Laurés AS; Casal Alvarez F
    Med Clin (Barc); 2015 Mar; 144(5):236-7. PubMed ID: 24939699
    [No Abstract]   [Full Text] [Related]  

  • 20. [Benign and malignant pheochromocytoma].
    Lehnert H; Hahn K; Dralle H
    Internist (Berl); 2002 Feb; 43(2):196, 199-209. PubMed ID: 11963757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.